Insurance Coverage, and Having a Regular Provider, and Utilization of Cancer Follow-up and Noncancer Health Care Among Childhood Cancer Survivors.

Inquiry : a Journal of Medical Care Organization, Provision and Financing
Michael R CousineauJoel E Milam

Abstract

The objective of this study was to assess the role of health insurance coverage on patterns of health care utilization and access to cancer-related follow-up and non-cancer care among childhood cancer survivors (CCS). Cross-sectional survey design was used. Childhood cancer survivors were from 2 large hospitals in Los Angeles County. In all, 235 were identified through the Los Angeles Cancer Surveillance Program, diagnosed between the ages of 5 and 18 in 2000-2007 with any cancer type except Hodgkin lymphoma. At data collection in 2009-2010, participants were between 15 and 25 years old. Study exposure was health insurance coverage (private, public, and uninsured). Main outcomes and measures were respondents' regular source of care for cancer follow-up, noncancer care, and both; and having a cancer follow-up visit, primary care visit, and hospital emergency department visit in the past 2 years. Compared with those with private insurance, the uninsured were less likely to have a regular source for cancer follow-up (odds ratio [OR] = 4.3, 95% confidence interval [CI] = 1.9-9.4), less likely to have a source for noncancer care (OR = 3.3, 95% CI 1.6-6.9), and less likely to have a source of care for both (OR = 5.3, 95% CI = 2.1-13....Continue Reading

References

Apr 1, 2004·Annals of Family Medicine·Kevin C OeffingerLeslie L Robison
Mar 11, 2005·Health Affairs·Marsha Lillie-Blanton, Catherine Hoffman
Dec 2, 2005·Pediatric Blood & Cancer·Jill P GinsbergAnna T Meadows
Sep 20, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Paul C NathanKevin C Oeffinger
Mar 3, 2009·Diabetes Care·Jennifer E DeVoeLorraine S Wallace
Jun 23, 2010·Cancer Causes & Control : CCC·Daixin YinLihua Liu
Jan 29, 2011·Journal of Cancer Survivorship : Research and Practice·Linda C HarlanUNKNOWN AYA HOPE Study Collaborative Group
Jan 11, 2014·Journal of Cancer Survivorship : Research and Practice·Theresa H M KeeganUNKNOWN AYA HOPE Study Collaborative Group
Mar 25, 2014·Annals of Emergency Medicine·Peter B SmulowitzBruce E Landon
Sep 26, 2014·Joint Commission Journal on Quality and Patient Safety·Robin M WeinickClarissa D Sellers
Oct 3, 2014·Journal of Adolescent and Young Adult Oncology·Molly H GardnerAvi Madan-Swain
Jul 29, 2015·JAMA : the Journal of the American Medical Association·Benjamin D SommersThomas Musco
Dec 15, 2015·Journal of Cancer Survivorship : Research and Practice·Wafa W TaraziLindsay M Sabik
Dec 13, 2016·Pediatrics·Kandyce LarsonLynn M Olson
Jan 5, 2017·The Lancet Oncology·Linda A Jacobs, Lawrence N Shulman
Jan 10, 2017·Healthcare : the Journal of Delivery Science and Innovation·James B Kirby, Ravi Sharma
May 26, 2017·The Cancer Journal·Christine LeopoldLarissa Nekhlyudov
Apr 17, 2018·Journal of Cancer Survivorship : Research and Practice·Giselle K PerezElyse R Park

❮ Previous
Next ❯

Citations

May 12, 2018·International Journal of Health Economics and Management·Conor KeeganSteve Thomas
Sep 19, 2019·Inquiry : a Journal of Medical Care Organization, Provision and Financing·Susan LeeAntje Dresen
Aug 12, 2021·Health Services Research·Erin M MobleyJoel E Milam

❮ Previous
Next ❯

Software Mentioned

SAS

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.